en

PRODUCT DETAIL

Lucentis 10 mg/ml injekčný roztok v naplnenej injekčnej striekačke

Code 9706A
MA number EU/1/06/374/003
Product Form: sol inj 1x0,165 ml ml/1,65 mg (striek.inj.napl.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Novartis Europharm Limited, Ireland
Therapeutic Class: 64 - OPHTHALMOLOGICA
ATC:
S SENSORY ORGANS
S01 OPHTHALMOLOGICALS
S01L Ocular vascular disorder agents
S01LA Antineovascularisation agents
S01LA04 Ranibizumab
Shelf life: 36
Container: glass vial
Route of admin.: Intravitreal use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 22.01.2007
SmPC + PL: European Medicines Agency's database
Dokument: DHCP Lucentis 10 5 2011.pdf  
Dokument: DHCP Lucentis 22 2 2011.pdf  
Dokument: Ranibizumab_Prirucka pre pacientov.pdf  
Safety feature Yes
Data update: 19.06.2018
eu-flag.png sk-flag.png